325 related articles for article (PubMed ID: 17718044)
1. [The anti-calcineurins (cyclosporin and tacrolimus)].
Raymond S; Limat S; Woronoff-Lemsi MC
Soins; 2007 Jun; (716):61-3. PubMed ID: 17718044
[No Abstract] [Full Text] [Related]
2. Induction of the unfolded protein response by calcineurin inhibitors: a double-edged sword in renal transplantation.
Kitamura M
Nephrol Dial Transplant; 2010 Jan; 25(1):6-9. PubMed ID: 19797334
[No Abstract] [Full Text] [Related]
3. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of calcineurin antagonists.
Kapturczak MH; Meier-Kriesche HU; Kaplan B
Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
[TBL] [Abstract][Full Text] [Related]
5. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
6. ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications.
van Gelder T; Klupp J; Sawamoto T; Christians U; Morris RE
Transplant Proc; 2001 May; 33(3):2420-1. PubMed ID: 11377580
[No Abstract] [Full Text] [Related]
7. [Role of calcineurin-dependent drugs on the immunosuppressive effect induced by the anti-LFA-1 antibody in a fetal intestinal transplantation model in mice].
Crétolle-Vastel C; Camby C; Cerf-Bensussan N; Cavazzana-Calvo M; Fischer A; Révillon Y; Sarnacki S
Chirurgie; 1999 Nov; 124(5):503-10. PubMed ID: 10615777
[TBL] [Abstract][Full Text] [Related]
8. Statistical process control and calcineurin inhibitor management.
Dunn SP
J Pediatr; 2005 Jun; 146(6):720-1. PubMed ID: 15973304
[No Abstract] [Full Text] [Related]
9. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
11. [Selection of organ transplant drugs is increasing].
Isoniemi H; Jalanko H
Duodecim; 2004; 120(11):1371-8. PubMed ID: 15327090
[No Abstract] [Full Text] [Related]
12. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
13. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Chang SH; Russ GR; Chadban SJ; Campbell S; McDonald SP
Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitors in heart transplantation.
Crespo-Leiro MG
Transplant Proc; 2005 Nov; 37(9):4018-20. PubMed ID: 16386614
[TBL] [Abstract][Full Text] [Related]
15. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen.
Helmschrott M; Beckendorf J; Akyol C; Ruhparwar A; Schmack B; Erbel C; Gleissner CA; Akhavanpoor M; Ehlermann P; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2014; 8():1307-14. PubMed ID: 25246772
[TBL] [Abstract][Full Text] [Related]
16. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
17. The CARI guidelines. Calcineurin inhibitors in paediatric renal transplantation.
McTaggart S;
Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S106-10. PubMed ID: 17316270
[No Abstract] [Full Text] [Related]
18. [Immunosuppressive therapy without calcineurin inhibitors for renal transplants? Perhaps we should be cautions...].
Fasoli G
G Ital Nefrol; 2007; 24(2):110. PubMed ID: 17458825
[No Abstract] [Full Text] [Related]
19. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Chapman JR; Nankivell BJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
